Sarah Cannon Research Institute
Preston Paul, CSM, is a seasoned professional with extensive experience in research and project management. Currently serving as a Research Product Analyst II at the Sarah Cannon Research Institute since June 2022, Preston has previously held various roles at HCA Healthcare, including Project Manager and Associate Project Manager, from April 2021 to October 2022. Experience also includes work as a Core Sales & Service Specialist at REI and a Facility Control Officer with U.S. Immigration and Customs Enforcement. A veteran of the US Army, Preston served as an Infantryman and Squad Leader from March 2011 to January 2017. Preston holds a Bachelor of Science degree in Accounting and Liberal Studies from Belmont University, completed in 2020.
This person is not in any teams
Sarah Cannon Research Institute
Sarah Cannon Research Institute (SCRI) is one of the world’s leading oncology research organizations conducting community-based clinical trials. In 2022, SCRI formed a joint venture with former US Oncology Research to enhance clinical trial access and availability across the country. Focused on advancing therapies for patients over the last three decades, SCRI is a leader in drug development. It has conducted nearly 700 first-in-human clinical trials since its inception and contributed to pivotal research that has led to the majority of new cancer therapies approved by the FDA today. The combined research network brings together physicians who are actively accruing patients to clinical trials at more than 250 locations in 26 states across the US.